1. Home
  2. GANX vs AEYE Comparison

GANX vs AEYE Comparison

Compare GANX & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.75

Market Cap

78.5M

Sector

Health Care

ML Signal

HOLD

AEYE

AudioEye Inc.

HOLD

Current Price

$5.67

Market Cap

83.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
AEYE
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
78.5M
83.6M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
GANX
AEYE
Price
$1.75
$5.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$7.50
$14.63
AVG Volume (30 Days)
792.5K
157.5K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
31.46
30.56
EPS
N/A
N/A
Revenue
$55,180.00
$40,311,000.00
Revenue This Year
N/A
$11.12
Revenue Next Year
N/A
$11.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.52
52 Week Low
$1.41
$5.31
52 Week High
$4.34
$16.39

Technical Indicators

Market Signals
Indicator
GANX
AEYE
Relative Strength Index (RSI) 48.92 34.50
Support Level $1.66 $5.45
Resistance Level $2.09 $7.40
Average True Range (ATR) 0.11 0.37
MACD 0.00 -0.12
Stochastic Oscillator 60.00 4.06

Price Performance

Historical Comparison
GANX
AEYE

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.

Share on Social Networks: